Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : MCRB save search
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -2.31%
H: 3.86%
C: -1.47%
ser-155 for trial therapeutics
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
Published: 2024-03-19 (Crawled : 12:30) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 0.0%
H: 1.42%
C: -2.56%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: -1.57%
H: 1.48%
C: -1.37%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.22%
H: 12.36%
C: 6.11%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.35%
H: 1.59%
C: 1.16%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.01%
H: 5.45%
C: 3.41%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.75%
H: 3.41%
C: 3.01%
companies
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
Published: 2024-02-28 (Crawled : 13:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.0%
H: 7.89%
C: 0.88%
conference therapeutics financial results
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
Published: 2024-02-27 (Crawled : 14:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.0%
H: 8.41%
C: 6.54%
conference therapeutics
Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
Published: 2024-02-26 (Crawled : 17:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -0.94%
H: 3.81%
C: 1.9%
therapeutics financial
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - January 17, 2024
Published: 2024-01-17 (Crawled : 14:30) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -2.44%
H: 9.17%
C: 7.5%
nasdaq grants therapeutics
Seres Therapeutics Announces VOWST™ Commercial Launch Update and US FDA Fast Track Designation for SER-155
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 26.92%
H: 3.54%
C: -27.78%
ser-155 fda update designation commercial therapeutics
Hematopoietic Stem Cell Transplantation Market to Grow Rapidly During the Study Period (2019-2032), Evaluates DelveInsight
Published: 2024-01-08 (Crawled : 22:00) - prnewswire.com
INAB | $1.035 3.51% 3.39% 280K
|
|
| O: 2.67%
H: 13.64%
C: 9.74%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 26.92%
H: 3.54%
C: -27.78%
DTIL | $10.33 6.72% 6.29% 31K
|
Health Technology
|
| O: 10.0%
H: 14.23%
C: 0.09%
OMER | $3.08 0.0% 210K
|
Health Technology
|
| O: -0.56%
H: 13.38%
C: 11.27%
MRKR | $4.43 5.73% 5.42% 12K
|
Consumer Services
|
| O: 1.21%
H: 0.0%
C: -0.8%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.0%
H: 0.53%
C: -2.19%
cell study market
Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
Published: 2024-01-05 (Crawled : 17:00) - biospace.com/
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 1.41%
H: 0.37%
C: -18.55%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: 2.04%
H: 10.8%
C: 2.0%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.71%
H: 2.84%
C: -0.71%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.82%
H: 7.46%
C: 3.11%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.79%
H: 7.65%
C: 2.55%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -2.47%
H: 0.66%
C: -2.18%
update fibrosis research
Seres Therapeutics Announces Presentation of Preliminary PK/PD and Safety Data for Investigational Microbiome Therapeutic SER-155 at ASH 2023
Published: 2023-12-08 (Crawled : 08:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 2.73%
H: 3.54%
C: -3.54%
ser-155 presentation therapeutics
Seres Therapeutics to Participate in the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023; Webcast at 3:30 p.m. ET
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -2.59%
H: 2.65%
C: 0.0%
conference therapeutics
Flagship Pioneering Marks Official Opening of UK Hub with Event Convening Life Science Leaders
Published: 2023-11-28 (Crawled : 00:00) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: -1.07%
H: 2.15%
C: -1.62%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: -0.24%
H: 3.07%
C: 0.24%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -2.59%
H: 2.65%
C: 0.0%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.51%
H: 1.2%
C: 1.11%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.84%
H: 0.47%
C: -1.64%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: 0.17%
H: 2.23%
C: 1.95%
life
Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics
Published: 2023-11-21 (Crawled : 11:00) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 0.0%
H: 2.99%
C: -4.5%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: -2.09%
H: 0.48%
C: -4.75%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 10.3%
H: 10.28%
C: -2.34%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -2.38%
H: 0.77%
C: 0.08%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: 0.0%
H: 4.14%
C: 0.0%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -2.34%
H: 0.0%
C: -2.83%
frontier therapeutics
Seres Therapeutics to Highlight VOWST™ Data at IDWeek
Published: 2023-10-12 (Crawled : 12:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -1.18%
H: 0.6%
C: -11.68%
therapeutics
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)-October 6, 2023
Published: 2023-10-06 (Crawled : 13:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -2.15%
H: 0.49%
C: -4.63%
nasdaq grants therapeutics
Flagship Pioneering Appoints John Lepore as CEO-Partner and CEO of ProFound Therapeutics
Published: 2023-10-02 (Crawled : 11:00) - prnewswire.com
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 4.65%
H: 0.0%
C: -16.0%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: -0.26%
H: 0.0%
C: -7.25%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -9.66%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.16%
H: 0.91%
C: 0.18%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.0%
H: 0.83%
C: -10.3%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: -3.6%
ceo therapeutics
Graft Versus Host Disease Market to Witness Upsurge in Growth During the Forecast Period (2023-2032), Assesses DelveInsight | Key Companies - Glia, Incyte, Novartis, GlaxoSmithKline, Pfizer, BMS, Roche, AstraZeneca, Sanofi
Published: 2023-09-27 (Crawled : 21:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -2.28%
H: 0.0%
C: -0.06%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.42%
H: 0.63%
C: -0.42%
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
|
| O: -1.61%
H: 0.0%
C: 0.0%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: 0.03%
H: 0.34%
C: -0.88%
disease companies sanofi growth market
ProFound Therapeutics Expands Leadership Team With Appointment of Klaus Urbahns as Chief Scientific Officer
Published: 2023-09-25 (Crawled : 13:00) - biospace.com/
OMGA | $2.345 -1.88% -1.92% 300K
|
|
| O: 0.32%
H: 0.95%
C: -4.76%
SANA | $8.09 2.02% 1.98% 1.7M
|
|
| O: 3.92%
H: 2.01%
C: -1.26%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: 0.0%
H: 1.53%
C: -7.66%
MRNA | News S | $107.87 3.26% 3.16% 2.4M
|
Health Technology
|
| O: -0.47%
H: 0.28%
C: -1.36%
FHTX | $5.135 1.68% 1.66% 46K
|
Health Technology
|
| O: -1.16%
H: 3.68%
C: 2.51%
DNLI | $16.11 0.75% 0.74% 1.1M
|
Health Technology
|
| O: -0.36%
H: 1.0%
C: -0.36%
therapeutics
Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - September 8, 2023
Published: 2023-09-08 (Crawled : 18:00) - biospace.com/
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -0.93%
H: 2.02%
C: 0.62%
nasdaq grants therapeutics
Seres Therapeutics to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
Published: 2023-09-07 (Crawled : 14:30) - biospace.com/
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.12%
H: 0.0%
C: 0.0%
MCRB | $0.7629 22.14% 18.13% 12M
|
Health Technology
|
| O: -0.94%
H: 4.11%
C: 2.53%
conference global therapeutics
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.